These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 12857895)

  • 1. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.
    Vogels R; Zuijdgeest D; van Rijnsoever R; Hartkoorn E; Damen I; de Béthune MP; Kostense S; Penders G; Helmus N; Koudstaal W; Cecchini M; Wetterwald A; Sprangers M; Lemckert A; Ophorst O; Koel B; van Meerendonk M; Quax P; Panitti L; Grimbergen J; Bout A; Goudsmit J; Havenga M
    J Virol; 2003 Aug; 77(15):8263-71. PubMed ID: 12857895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: low seroprevalence and non-cross-reactivity with Ad5.
    Holterman L; Vogels R; van der Vlugt R; Sieuwerts M; Grimbergen J; Kaspers J; Geelen E; van der Helm E; Lemckert A; Gillissen G; Verhaagh S; Custers J; Zuijdgeest D; Berkhout B; Bakker M; Quax P; Goudsmit J; Havenga M
    J Virol; 2004 Dec; 78(23):13207-15. PubMed ID: 15542673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a replication-deficient recombinant human adenovirus type 35 vector using bacteria-mediated homologous recombination.
    Wu C; Lei X; Wang J; Hung T
    J Virol Methods; 2011 Oct; 177(1):55-63. PubMed ID: 21763350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
    Lemckert AAC; Grimbergen J; Smits S; Hartkoorn E; Holterman L; Berkhout B; Barouch DH; Vogels R; Quax P; Goudsmit J; Havenga MJE
    J Gen Virol; 2006 Oct; 87(Pt 10):2891-2899. PubMed ID: 16963747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adenovirus type 35: nucleotide sequence and vector development.
    Gao W; Robbins PD; Gambotto A
    Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge.
    Geisbert TW; Bailey M; Hensley L; Asiedu C; Geisbert J; Stanley D; Honko A; Johnson J; Mulangu S; Pau MG; Custers J; Vellinga J; Hendriks J; Jahrling P; Roederer M; Goudsmit J; Koup R; Sullivan NJ
    J Virol; 2011 May; 85(9):4222-33. PubMed ID: 21325402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of adenovirus serotype 35 as a gene transfer vector.
    Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
    Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.
    Lemckert AA; Sumida SM; Holterman L; Vogels R; Truitt DM; Lynch DM; Nanda A; Ewald BA; Gorgone DA; Lifton MA; Goudsmit J; Havenga MJ; Barouch DH
    J Virol; 2005 Aug; 79(15):9694-701. PubMed ID: 16014931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
    Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
    Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture.
    Bangari DS; Mittal SK
    Virus Res; 2004 Oct; 105(2):127-36. PubMed ID: 15351486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35].
    Sakurai F
    Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.
    Bruder JT; Chen P; Semenova E; Thomas CA; Konovalova S; Ekberg G; Ettyreddy D; McVey D; Gall JG; King CR; Brough DE
    J Virol; 2013 Sep; 87(17):9661-71. PubMed ID: 23824800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.
    Sumida SM; Truitt DM; Kishko MG; Arthur JC; Jackson SS; Gorgone DA; Lifton MA; Koudstaal W; Pau MG; Kostense S; Havenga MJ; Goudsmit J; Letvin NL; Barouch DH
    J Virol; 2004 Mar; 78(6):2666-73. PubMed ID: 14990686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
    Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
    J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.
    Parker AL; White KM; Lavery CA; Custers J; Waddington SN; Baker AH
    Gene Ther; 2013 Dec; 20(12):1158-64. PubMed ID: 24005577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector.
    Sakurai F; Mizuguchi H; Yamaguchi T; Hayakawa T
    Mol Ther; 2003 Nov; 8(5):813-21. PubMed ID: 14599815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.